I am a breastfeeding mother and i want to know if it is safe to use 1,3-Bis(2-chloroethyl)-1-nitrosourea? Is 1,3-Bis(2-chloroethyl)-1-nitrosourea safe for nursing mother and child? Does 1,3-Bis(2-chloroethyl)-1-nitrosourea extracts into breast milk? Does 1,3-Bis(2-chloroethyl)-1-nitrosourea has any long term or short term side effects on infants? Can 1,3-Bis(2-chloroethyl)-1-nitrosourea influence milk supply or can 1,3-Bis(2-chloroethyl)-1-nitrosourea decrease milk supply in lactating mothers?
- DrLact safety Score for 1,3-Bis(2-chloroethyl)-1-nitrosourea is 7 out of 8 which is considered Dangerous as per our analyses.
- A safety Score of 7 indicates that usage of 1,3-Bis(2-chloroethyl)-1-nitrosourea may cause toxic or severe side effects in breastfed baby.
- Our study of different scientific research indicates that 1,3-Bis(2-chloroethyl)-1-nitrosourea may cause moderate to high side effects or may affect milk supply in lactating mother.
- Our suggestion is to use safer alternate options rather than using 1,3-Bis(2-chloroethyl)-1-nitrosourea .
- Usage of 1,3-Bis(2-chloroethyl)-1-nitrosourea is in contradiction to breastfeeding hence if it is must to use 1,3-Bis(2-chloroethyl)-1-nitrosourea and there is no better alternative available then breastfeeding shall be stopped permanently or temporarily.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Drug is cleared from the body after 25-50 elimination half-life. Resuming breastfeeding is likely safe after 48 hours of pump-and-dump.
No information is available on the use of 1,3-Bis(2-chloroethyl)-1-nitrosourea during breastfeeding. Most sources consider breastfeeding to be contraindicated during maternal antineoplastic drug therapy, especially alkylating agents such as 1,3-Bis(2-chloroethyl)-1-nitrosourea.[1] The manufacturer recommends that breastfeeding be discontinued during 1,3-Bis(2-chloroethyl)-1-nitrosourea therapy and for 1 month after the last dose.
Some evidence indicates that 1,3-Bis(2-chloroethyl)-1-nitrosourea can increase serum prolactin.[2]
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.